Medical News

RSS

'Modern' patients help drive up health care costs

Patients who request specific medications and procedures, even though they may not need them, help to drive up health care costs, NPR reports.

12 Oct 2009

Communications technology for students and employees to manage their healthcare relationships

Allviant Corporation today announced the launch of its CarePass™ pilot program with Arizona State University to add another tool to the university’s health and wellness communications and services while empowering its employees and students with tools to manage their healthcare relationships.

12 Oct 2009

Xoft to showcase a variety of investigational IORT oncology applications at ACS Annual Congress

Clinical experience with the FDA cleared Axxent® Electronic Brachytherapy, eBx(TM), System from Xoft shows promise for the multi-disciplinary use of the isotope-free cancer treatment platform to deliver intraoperative radiation therapy (IORT). Xoft will showcase a variety of investigational IORT oncology applications at the American College of Surgeons 95th Annual Clinical Congress here in Chicago, October 11-15, 2009.

12 Oct 2009

Synta Pharmaceuticals updates its Phase 3 SYMMETRY trial results at the Melanoma XIII Conference

Synta Pharmaceuticals Corp., a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today announced that additional results from its Phase 3 trial (SYMMETRYSM) of elesclomol in combination with paclitaxel in metastatic melanoma was presented at the Perspectives in Melanoma XIII Conference by Steven O’Day, M.D., principal investigator and Chief of Research and Director of the Melanoma Program at the Angeles Clinic in Santa Monica, California.

12 Oct 2009

The Hallowell Centers include beneficial exercises in treatment of ADHD

New brain research is unlocking long-standing mysteries, explaining how the brain trains itself and how human beings develop their superior cognitive skills. New scanning tools (FMRI, SPECT, QEEG, etc.) are advancing neurology's understanding of a process called neuroplasticity and shedding light on a simple looking balance and movement regimen used since 1982 by developmental specialists to treat people with ADHD, Dyslexia and other learning differences.

12 Oct 2009

TomoTherapy to present an update on TomoTherapy radiation therapy platform

TomoTherapy Incorporated announced today that it will host an analyst and investor presentation in conjunction with the annual ASTRO (American Society for Radiation Oncology) meeting on Monday, Nov. 2, 2009, at 8:00 a.m. CT.

12 Oct 2009

Study on Lumalier's automated UV device for decontaminating hospital rooms presented at the ICAAC

In a study presented at the 49th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), researchers used a mobile, automated UV device to decontaminate hospital rooms at the Cleveland Veterans Affairs (VA) Medical Center in Ohio and analyzed its ability to remove troublesome bacteria, including C. difficile spores.

12 Oct 2009

Buehler Motor relocates and expands its U.S. headquarters

Buehler Motor, Inc. (BMI), a leading international provider of mechatronic drive solutions, has relocated and expanded its U.S. headquarters to allow it to better provide its customers in automotive, aerospace, medical devices, office and building automation with the latest advances in green technology.

12 Oct 2009

XTend Medical provides update regarding the BioHarp market potential

XTend Medical, a company specializing in manufacturing and distributing the latest in telemedicine and diagnostic devices, released the following information regarding the BioHarp market potential.

12 Oct 2009

Noveko International closes initial amount of $11.7 million private placement

Noveko International Inc. ("the Company") is pleased to announce the closing of an initial amount of $11.7 million (the "first Closing") of its previously announced best efforts private placement (the "Offering"). It is expected that a second and final closing of the Offering will occur no later than October 30, 2009.

12 Oct 2009

Wolverine Venture Fund to participate in Direct Flow Medical's Series C round of financing

Wolverine Venture Fund (WVF), managed by The Samuel Zell & Robert H. Lurie Institute for Entrepreneurial Studies at the University of Michigan Ross School of Business, today announced participation in Direct Flow Medical Inc.'s Series C round of financing. Direct Flow Medical is an emerging medical device company developing a next-generation, catheter based, percutaneous-delivered prosthetic aortic valve.

12 Oct 2009

Holistic care needed for people with Alzheimer's disease and dementia

Whilst cognitive function can be improved by the medicines currently available for the treatment of dementias, the positive effects of improved socialibility, initiative and motivation on the patient and their carer as well as their capability of coping with everyday life should not be overlooked says a research report published by the Pharmacy Practice Research Trust (the Trust).

12 Oct 2009

Rice consumption improves overall diet and reduces obesity and Type II diabetes

According to recent research published in the October issue of the Journal of the American Dietetic Association (JADA), eating rice helps improve overall diet and potentially reduces the risk for many chronic diseases, including obesity, cardiovascular disease and Type II diabetes.

12 Oct 2009

ImmuneRegen BioSciences to test efficacy of Homspera against H5N1 Avian Influenza

ImmuneRegen BioSciences, Inc.®, a wholly owned subsidiary of IR Biosciences Holdings, Inc. (OTCBB: IRBS), today announced that its lead anti-influenza drug, Homspera, will be tested for efficacy against highly lethal H5N1 Avian Influenza in the laboratories of a widely respected University scientist. Additionally, testing at an independent facility will further define the adjuvant efficacy of Homspera when coupled with a novel vaccine for H5N1 in studies sponsored by an ImmuneRegen industry partner.

12 Oct 2009

Orion Genomics enters collaboration and license agreement with Novartis Pharma

Orion Genomics today announced that it has entered into a multi-year collaboration and license agreement with the molecular diagnostics unit of Novartis Pharma AG. Under the collaboration, the parties seek to discover novel epigenetic biomarkers, and both parties have rights to independently develop and commercialize diagnostic products in their respective fields.

12 Oct 2009

Celator Pharmaceuticals enrolls 120 patients in CPX-351 Phase 2 study

Celator Pharmaceuticals today announced that it has completed enrollment in its Phase 2 multicenter, randomized, open-label clinical trial of CPX-351 (Cytarabine:Daunorubicin) Liposome Injection versus conventional cytarabine and daunorubicin therapy ("7+3") in patients 60-75 years of age with untreated acute myeloid leukemia (AML).

12 Oct 2009

OSI Systems receives $1.3 million order from Thomas Memorial Hospital for its patient monitoring products

OSI Systems, Inc., a vertically-integrated provider of specialized electronic products for critical applications in the Security and Healthcare industries, today announced that its Healthcare division, Spacelabs Healthcare, has received a contract from Thomas Memorial Hospital in Charleston, West Virginia for a broad range of patient monitoring products.

12 Oct 2009

CED to host popular STREAK program

CED, formerly the Council for Entrepreneurial Development (www.cednc.org), a private, nonprofit organization that promotes entrepreneurial efforts in the Triangle region of North Carolina, has announced that it will host the next installment of its popular STREAK program, to be held Thursday, Oct. 8 from 3 p.m. to 5 p.m.

12 Oct 2009

Public option for the House bill still viable

House Speaker Nancy Pelosi's record of passing all the bills she has brought forward -- despite opponents' caricature of her as inept -- mean that the health public option remains viable in the House and the House-Senate conference, says ex-White House staffer and former House Aging Committee and Health Subcommittee Chief of Staff Robert Weiner. Pelosi told Weiner, "We will not be deterred. We will pass the bill."

12 Oct 2009

OptumHealth’s conference to focus on advancements in fetal diagnosis and treatment

OptumHealth Inc. has teamed with The Children’s Hospital of Philadelphia (CHOP) to present a two-day educational conference focused on clinical advancements in fetal diagnosis and treatment, neonatal care and pediatric care. The gathering runs through today, and is part of OptumHealth’s Network Spotlight Conferences program.

12 Oct 2009

Medical News

'Modern' patients help drive up health care costs

Communications technology for students and employees to manage their healthcare relationships

Xoft to showcase a variety of investigational IORT oncology applications at ACS Annual Congress

Synta Pharmaceuticals updates its Phase 3 SYMMETRY trial results at the Melanoma XIII Conference

The Hallowell Centers include beneficial exercises in treatment of ADHD

TomoTherapy to present an update on TomoTherapy radiation therapy platform

Study on Lumalier's automated UV device for decontaminating hospital rooms presented at the ICAAC

Buehler Motor relocates and expands its U.S. headquarters

XTend Medical provides update regarding the BioHarp market potential

Noveko International closes initial amount of $11.7 million private placement

Wolverine Venture Fund to participate in Direct Flow Medical's Series C round of financing

Holistic care needed for people with Alzheimer's disease and dementia

Rice consumption improves overall diet and reduces obesity and Type II diabetes

ImmuneRegen BioSciences to test efficacy of Homspera against H5N1 Avian Influenza

Orion Genomics enters collaboration and license agreement with Novartis Pharma

Celator Pharmaceuticals enrolls 120 patients in CPX-351 Phase 2 study

OSI Systems receives $1.3 million order from Thomas Memorial Hospital for its patient monitoring products

CED to host popular STREAK program

Public option for the House bill still viable

OptumHealth’s conference to focus on advancements in fetal diagnosis and treatment

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Bioprocess Efficiency with Cell Density Monitoring

Latest News